OriGene Technologies Launches 5,000 Human Antigen Standards for Antibody Validation

OriGene Technologies, Inc. announces it has launched a new product line for antibody validation; VERIFY™ Antigen Standard; a collection of tagged over-expression cell lysates to be used as Western blot standards. The offering covers 5,000 over-expressed human proteins, each with a built-in C-terminal Myc/DDK tag for expression verification and antibody validation.

The availability of these initial 5000 VERIFY™ Antigen Standards will not only provide scientists with access to a validated antigen of interest, they can also be quantified with Myc/DDK tag standard hence providing definitive detection sensitivity of a particular antibody.

Built on its strength as the leading full-length cDNA clone provider and extensive TrueORF clone collection, OriGene has developed comprehensive, protein specific over-expression cell lysates for antibody validation. The first 5,000 offerings are primarily for Western blot standards.